학술논문
Shorter Crohn’s Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies
Document Type
Article
Author
Source
In Gastro Hep Advances 2024 3(4):539-550
Subject
Language
ISSN
2772-5723